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Urinary tract morbidity due to Schistosoma haematobium infection in
Mali. A total of 824 Malian villagers in a region endemic for Schistosoma
(S.) haematobium were examined clinically, parasitologically and by
abdominal ultrasound. Systematic schistosomicidal treatment had never
been applied to this population. Prevalence of S. haematobium infection
ranged from 77% in adolescents to 51% in adults older than 40 years.
Intensity of infection was generally mild, 91% of all patients excreting less
than 100 ova/lO ml urine. Bladder wall enlargement and irregularities,
bladder masses, pseudopolyps and dilation of the upper urinary tract were
found ultrasonographically in about one third of infected individuals.
Bladder lesions were more frequent in children than in adults and
correlated with the intensity of infection in younger age groups only.
Hydronephrosis was rare (7 of 824) and never seen in uninfected
individuals. Prevalence of urinary tract pathology dropped significantly
with age (P < 0.001) and was lowest in patients older than 40 years.
Logistical regression identified age and infection as independent param-
eters affecting the prevalence of urinary tract pathology (P < 0,001). We
conclude that Schistosoma haematobium infection causes substantial mor-
bidity in children and younger adults. The reduction of urinary tract
morbidity with age despite a considerable prevalence of infection in older
age groups suggests spontaneous resolution during adulthood in most
cases.
Schistosoma haematobium infection is a major cause of urinary
tract pathology in countries where this disease is endemic [1, 2].
Reports in the seventies revealed that S. haematobium induced
urinary tract obstruction led to renal dysfunction [3] and an
increased mortality rate in untreated patients [4, 5]. Ultrasono-
graphy has proven to be a reliable tool in detecting schistosomal
uropathy [6]. Field studies using ultrasound showed prevalence
rates of bladder and upper urinary tract pathology in up to 80%
and 50%, respectively, in patients with urinary schistosomiasis [7,
8]. Substantial improvement ofurinary tract pathology was docu-
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mented within one year after schistosomicidal treatment [7, 9],
Some authors have speculated that spontaneous resolution may
occur [10, 11], but demographic evidence for this hypothesis is still
lacking.
We examined 824 inhabitants of three villages in Mali to
provide data on S. haematobium morbidity in children and adults
according to age and intensity of infection.
METHODS
Our study was conducted in eastern and central Mali. Three
villages (Nara, NDI I and Koundougou) endemic for Schistosoma
haematobium were chosen because systematic schistosomicidal
treatment had never been applied to the population. Nara and
ND11 were endemic for Schistosoma mansoni as well, and data on
liver involvement in these patients have been published elsewhere
[12]. S. haematobium monoinfection was found in Koundougou.
All inhabitants older than two years were examined to allow
comparison of infection and morbidity in different age groups.
A total of 824 out of 961 inhabitants were included in the study.
Two hundred sixty-three (32%) were children up to 10 years, 175
(21%) adolescents of 11 to 20 years; 221 (27%) were young adults
between 21 and 40 years, 165 (20%) were older than 40 years. The
remaining 137 inhabitants were excluded from the analysis be-
cause of incompleteness of data.
All patients underwent a complete physical examination. Schis-
tosoma haematobium infection was confirmed by filtration of 10
ml aliquots of urine, collected in the morning. The specimens
were stained with ninhydrine and the intensity of infection was
calculated as ova per 10 ml of urine. Up to three microscopical
investigations were done to exclude infection. Ultrasonography
was performed using a Hellige-Aloka SSD 500 Echo camera
equipped with a Mitsubishi P-66 thermal printer. Urinary tract
and kidneys were examined according to WHO standards [13].
The bladder was evaluated using a 3.5 MHz sector scan in three
directions. Adequate filling of the bladder was assured. Bladder
wall thickness was measured in the trigone region, and mucosal
irregularities, masses or pseudopolyps were classified as proposed
by the WHO Workshop [13]. Ureter dilation was evaluated in the
retrovesical region and if indicated this examination was repeated
after micturition to exclude vesico-ureteral refiux. A 3.5 MHz
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Fig. 1. Prevalence of bladder lesions according to intensity of S. haema-
tobium infection. Symbols are: (•) uninfected (N = 292); (111) 1—100 ova/lO
ml (N = 484); ) > 100 ova/lO ml (N = 48).
linear scan was used to measure kidney length as well as pyelon
depth and parenchymal thickness. This was done with the patient
in a prone position. Pyelon diameter was considered pathological
in the case of more than 8 mm in patients < 120 cm of height or
10 mm in patients > 120 cm. Renal parenchymal thickness was
regarded reduced if less than 10 mm. Hydronephrosis was defined
as pyelon dilation in combination with reduced renal parenchyma.
All study patients who were found to be infected with Schisto-
soma haematobiurn or mansoni were treated with praziquantel,
and all patients who were infected with other intestinal parasites
were treated with mebendazole. The studies were approved by the
Ministry of Health in Mali and the Ethical Committees of the
Universities of Bonn and Hannover. All patients with incidentally
detected diseases were treated according to local standards or
referred and transported to the next health center with transport
facilities provided by the study logistics.
Differences between groups of different intensity of infection
and different age groups were calculated using the Pearson-Chi-
square test. The influence of single parameters on urinary tract
morbidity was assessed by calculating the logistical regression.
The data on the correlation of clinical symptoms and urinary
reagent strip testing with intensity of infection and morbidity will
be published [14]. A detailed description of ureteric abnormalities
was published elsewhere [15].
RESULTS
The overall prevalence of S. haematobium infection was 65%
(532 of 824). The prevalence was slightly higher in Nara (71%)
and Koundougou (72%) than in ND11 (54%). By gender, 69% of
males and 61% of females were infected. Prevalence of S.
haematobium infection was higher in children and adolescents
(73% and 77%) than in young and older adults (55% and 51%).
The intensity of infection was generally mild, and low egg
excretion up to 100 ova per 10 ml urine was found in 91% of all
infected individuals. More than 100 ova per 10 ml urine were
found more often in children and adolescents (13% of infected
Fig. 2. Prevalence of upper urinary tract dilation according to intensity
of S. haematobium infection. Symbols are: (•) uninfected (N = 292); (ill)
1—100 ova/lO ml (N = 484); (U) > 100 ova/lO ml (N = 48).
persons) and less often in the older age groups (3% and 2% of
infected young and older adults).
On ultrasound examination most known features of schistoso-
miasis-associated urinary tract pathology were found, such as
bladder wall enlargement of more than 5 mm, bladder mucosa
irregularities, bladder masses and pseudopolyps, dilation of ureter
or pyelon and hydronephrosis. Bladder calcifications were not
found.
Prevalence of bladder lesions correlated with Schistosoma
haematobium infection and its severity (Fig. 1). More than 50% of
all patients showing more than 100 ova per 10 ml urine had at
least one type of bladder lesion. Bladder masses and pseudopol-
yps were mostly found in infected individuals. The correlation
between infection and bladder lesions was significant in children
younger than 10 years (P < 0.001) and not found in adults.
Dilation of the upper urinary tract was found in a substantial
proportion of the population (Fig. 2). A significant correlation was
found between Schistosoma haematobium infection and ureter
dilation in children younger than 10 years (P < 0.05), pyelon
dilation correlated with the infection in individuals 11 to 20 years
old (P < 0.05). Again, this correlation was not observed in adults.
Hydronephrosis was found in adolescents and younger adults only
and was never seen in uninfected persons.
Age was the second most important factor affecting the preva-
lence of bladder lesions (Fig. 3). Prevalence rates of bladder
lesions dropped with age (P < 0.001); bladder masses and
pseudopolyps were almost absent in adults.
Age related prevalence of upper urinary tract pathology was
found to be more frequent in individuals above 10 years of age
(Fig. 4). Dilation of the ureter was most frequent in children and
adolescents, whereas pyelon dilation and hydronephrosis was
most prevalent in adolescents and young adults. Individuals older
than forty years showed significantly less pathology when com-
pared with younger age groups (P < 0.001).
Logistical regression analysis revealed that besides infection,
age itself was an independent parameter leading to a lower
prevalence of bladder and upper urinary tract pathology in adults
(P < 0.001).
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Fig. 3. Prevalence of bladder lesions according
to age (infected and uninfected individuals).
Symbols are: (U) 2—10 years (N = 263); ()
11—20 years (N = 175); (U) 21—40 years (N =
221); () > 40 years (N = 165).
Fig. 4. Prevalence of upper urinary tract
dilation according to age (infected and
uninfected individuals). Symbols are: (U) 2—10
years (N = 263); () 11—20 years (N = 175);
(U) 21—40 years (N = 221); () > 40 years(N = 165).
DISCUSSION
Urinary tract pathology was found in a substantial number of S.
haematobium infected villagers in Mali despite a relatively low
intensity of infection during the study period. However, intensity
of infection might have been underestimated in our study because
urine samples were taken in the morning and not at noon [16].
Bladder lesions and ureter dilation correlated with egg excre-
tion in children younger than 10 years, and pyelon dilation
correlated with the intensity of infection in adolescents 11 to 20
years old. In adults the association between urinary tract pathol-
ogy and intensity of Schistosoma haematobium infection was less
obvious. This finding confirms previous reports documenting a
close correlation between intensity of infection and urinary tract
pathology in children [17, 18] but not in adults [2, 19], possibly
reflecting a more chronic stage of the inflammatory processes.
Higher prevalence rates of bladder lesions in childhood than irs
adulthood were seen in a community based study in Kenya [20] as
well as in Niger [2, 19, 21]. In contrast to our results on Malian
patients and the report from Kenya [20], Lamothe et al [19, 21] in
Niger described a higher prevalence of upper urinary tract
dilation in children younger than 15 years than in adults. This may
be explained by a higher intensity of infection in Niger that may
have accelerated the development of specific pathology.
The most striking finding in our study was a very low percentage
of schistosomiasis-related pathology in patients older than 40
years despite a prevalence of infection of more than 50%. This
was true for the bladder and the upper urinary tract. Logistical
regression documented that age itself was a significant predictor
for urinary tract pathology. This can be explained only by spon-
taneous regression of lesions, because substantial mortality in
adolescence and early adulthood was not reported in the study
villages.
Post-frusemide urography [22] and diuretic scintigraphy [23]
demonstrated the lack of urodynamically relevant obstruction in a
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majority of patients with schistosomal upper urinary tract pathol-
ogy. This could explain both the potential for complete recovery
following schistosomicidal treatment [7—9] and for spontaneous
resolution with preserved renal function.
We speculate from our data that lower urinary tract pathology
in Schistosoma haematobium infection develops early during
childhood and progresses to upper urinary tract dilation in a
substantial proportion of older patients if the infection is persis-
tent and heavy. Bladder lesions may already resolve spontane-
ously during adolescence, followed by a regression of upper
urinary tract pathology. This hypothesis is supported by the
finding of spontaneous resolution of S. haematobium-induced
morbidity in experimental infection in monkeys [24].
It should be stressed, however, that a small subgroup of patients
may develop hydronephrosis with consecutive obstructive renal
failure, indicating that there is indeed a risk for life-threatening
complications as supposed by others [5, 251. In our study 7 out of
824 inhabitants (0.85%) showed hydronephrosis on ultrasound
examination. The factors responsible for resolution or progression
of urinary tract pathology in schistosomiasis are still to be defined.
Since morbidity control is the main target of WHO policy [26],
further studies to identify patients at risk for progressive disease
are urgently needed.
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